NEOGENOMICS INC — Director's Dealing 2021

Jul 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-07-05

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-05	Common Stock	A	758	—	Acquired	27215	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-05	Stock Option (Right to Buy)	$43.95	A	4050	Acquired	2028-07-05	Common Stock (4050.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (7000.0)	7000	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (33334.0)	33334	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (17496.0)	17496	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (15006.0)	15006	Direct
Stock Option (Right to Buy)	$53.17	2028-03-02	Common Stock (10551.0)	10551	Direct

Footnotes

F1: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.

F2: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F6: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date.